search
Back to results

Prevention of Colic With the Probiotic Lactobacillus Reuteri

Primary Purpose

Colic

Status
Unknown status
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
Lactobacillus reuteri DSM 17938
Placebo
Sponsored by
Hospital General Naval de Alta Especialidad - Escuela Medico Naval
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Colic focused on measuring colic, probiotic, Lactobacillus reuteri, prevention

Eligibility Criteria

1 Day - 1 Week (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Term Healthy Newborns (RN) ≥38 weeks and ≤ 41 weeks of gestation.
  • Appropriate weight for gestational age
  • ≥than 8 Apgar at 5 minutes
  • Egress at the first 24-48 hours of life of the newborn with the mother of hospital
  • No congenital or physical abnormalities on physical examination at birth.
  • Availability during the study period.
  • Thorough understanding of the protocol by parents
  • Informed Consent is signed by both parents.

Exclusion Criteria:

  • Administration of antibiotics to the mother for a week before the birth of the newborn.
  • Administration of probiotics newborn before inclusion or consumption by the mother during these last two trimesters.
  • Medication Management newborn different routine prescribed at birth.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Placebo Comparator

    Arm Label

    Lactobacillus reuteri group

    Placebo group

    Arm Description

    Lactobacillus reuteri DSM 17938 1,000,000,000 CFU per day (5 drops) for 28 days

    Placebo (5 drops) for 28 days

    Outcomes

    Primary Outcome Measures

    Event number of colic

    Secondary Outcome Measures

    Full Information

    First Posted
    October 14, 2015
    Last Updated
    October 15, 2015
    Sponsor
    Hospital General Naval de Alta Especialidad - Escuela Medico Naval
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02577133
    Brief Title
    Prevention of Colic With the Probiotic Lactobacillus Reuteri
    Official Title
    Prevention of Colic With the Probiotic Lactobacillus Reuteri in Mexican Infants: Randomized, Double-blind Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2015
    Overall Recruitment Status
    Unknown status
    Study Start Date
    October 2015 (undefined)
    Primary Completion Date
    January 2016 (Anticipated)
    Study Completion Date
    October 2016 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Hospital General Naval de Alta Especialidad - Escuela Medico Naval

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Colic is a term for inconsolable crying happened in the first months of life. Its etiology is multifactorial and caregiver and pediatrician generates among other problems: anxiety, risk of child abuse as well as economic costs. There is now enough evidence for the treatment of colic using probiotics, especially Lactobacillus reuteri. The investigators study aims to demonstrate the utility for the prevention of colic with L. reuteri and thereby avoid the problems caused by this pathology. Objective: Compare the number of events of colic among infants with oral probiotic Lactobacillus reuteri during the first month of life versus infants with placebo Study Design. Double blind, randomized, controlled, 492 neonates of 37-42 gestational age, breast or formula fed, will receive L. reuteri 5 drops (1x108 CFU) daily or placebo for 28 days. The investigators trial will be performed at Naval Hospital in Mexico City.
    Detailed Description
    Methods: This study is planned for October 2015 to October 2016 aiming newborns born population in Naval Hospital Inclusion: Term Healthy Newborns (RN) ≥38 weeks and ≤ 41 weeks of gestation Appropriate weight for gestational age ≥than 8 Apgar at 5 minutes Egress at the first 24-48 hours of life of the newborn with the mother of hospital No congenital or physical abnormalities on physical examination at birth. Availability during the study period. Thorough understanding of the protocol by parents Informed Consent is signed by both parents. Exclusion: Administration of antibiotics to the mother for a week before the birth of the newborn. Administration of probiotics newborn before inclusion or consumption by the mother during these last two trimesters. Medication Management newborn different routine prescribed at birth. Elimination Loss of monitoring Abandonment by parents Diagnosis of allergy to cow's milk protein (confirmed by resolution of symptoms after switching to Formula hypo allergenic or free feeding cow's milk by the mother in breastfed children). Diagnosis of structural alterations or gastrointestinal illness to explain the symptoms of colic in the following months after the inclusion Interventions: The patients enrolled will receive probiotics (1000000000 CFU per day) or placebo every days for 28 days Weekly, each patient will be called twice to interrogate the number of events colic as well as the different variables under study After birth, on 15, 30, 45 and 60 of life will be cited for clinical examination and review and weight dropper bottle of probiotic • Principal: Number of events or inconsolable crying • Secondary: Average or evacuations / day Average or regurgitation / day Drugs to decrease excessive crying Medical reviews for excessive crying Changes feeding for excessive crying Level of satisfaction with the care of the newborn (numerical scale from 0: the worst possible, 10: completely satisfied) • Universal variables Weight: Size: Gender Weeks gestation Type of birth Feeding of formula / breast-

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Colic
    Keywords
    colic, probiotic, Lactobacillus reuteri, prevention

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Phase 2, Phase 3
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantInvestigator
    Allocation
    Randomized
    Enrollment
    478 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Lactobacillus reuteri group
    Arm Type
    Active Comparator
    Arm Description
    Lactobacillus reuteri DSM 17938 1,000,000,000 CFU per day (5 drops) for 28 days
    Arm Title
    Placebo group
    Arm Type
    Placebo Comparator
    Arm Description
    Placebo (5 drops) for 28 days
    Intervention Type
    Dietary Supplement
    Intervention Name(s)
    Lactobacillus reuteri DSM 17938
    Other Intervention Name(s)
    BioGaia
    Intervention Description
    Lactobacillus reuteri DSM 17938 1,000,000,000 CFU per day (5 drops) for 28 days
    Intervention Type
    Dietary Supplement
    Intervention Name(s)
    Placebo
    Intervention Description
    The placebo consisted of an identical bottle with distilled water
    Primary Outcome Measure Information:
    Title
    Event number of colic
    Time Frame
    3 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    1 Day
    Maximum Age & Unit of Time
    1 Week
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Term Healthy Newborns (RN) ≥38 weeks and ≤ 41 weeks of gestation. Appropriate weight for gestational age ≥than 8 Apgar at 5 minutes Egress at the first 24-48 hours of life of the newborn with the mother of hospital No congenital or physical abnormalities on physical examination at birth. Availability during the study period. Thorough understanding of the protocol by parents Informed Consent is signed by both parents. Exclusion Criteria: Administration of antibiotics to the mother for a week before the birth of the newborn. Administration of probiotics newborn before inclusion or consumption by the mother during these last two trimesters. Medication Management newborn different routine prescribed at birth.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Héctor Javier Varona Bobadilla, Dr.
    Phone
    (52) 55 56 24 65 00
    Ext
    5423
    Email
    kavel_555@hotmail.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Héctor Javier Varona Bobadilla, Dr.
    Organizational Affiliation
    Secretaria de Marina-Armada de México (Mexican Navy)
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    16678565
    Citation
    Hyman PE, Milla PJ, Benninga MA, Davidson GP, Fleisher DF, Taminiau J. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology. 2006 Apr;130(5):1519-26. doi: 10.1053/j.gastro.2005.11.065.
    Results Reference
    background
    PubMed Identifier
    13214956
    Citation
    WESSEL MA, COBB JC, JACKSON EB, HARRIS GS Jr, DETWILER AC. Paroxysmal fussing in infancy, sometimes called colic. Pediatrics. 1954 Nov;14(5):421-35. No abstract available.
    Results Reference
    background
    PubMed Identifier
    22174332
    Citation
    Douglas P, Hill P. Managing infants who cry excessively in the first few months of life. BMJ. 2011 Dec 15;343:d7772. doi: 10.1136/bmj.d7772. No abstract available.
    Results Reference
    background
    Citation
    E. Ortega Páeza , D. Barroso Espaderob Flashes pediátricos AEpap Cólico del lactante Rev Pediatr Aten Primaria Supl. 2013;(22):81-7
    Results Reference
    background
    Citation
    Wolke D, Samara M, Alvarez Wolke M. Meta-analysis of fuss/cry durations and colic prevalence across countries: Proceedings of the11th International Infant Cry Research Workshop, June, 2011, The Netherlands.
    Results Reference
    background
    PubMed Identifier
    22753793
    Citation
    Cohen GM, Albertini LW. Colic. Pediatr Rev. 2012 Jul;33(7):332-3; discussion 333. doi: 10.1542/pir.33-7-332. No abstract available.
    Results Reference
    background
    PubMed Identifier
    1614771
    Citation
    Barr RG, Rotman A, Yaremko J, Leduc D, Francoeur TE. The crying of infants with colic: a controlled empirical description. Pediatrics. 1992 Jul;90(1 Pt 1):14-21.
    Results Reference
    background
    PubMed Identifier
    23592105
    Citation
    Romanello S, Spiri D, Marcuzzi E, Zanin A, Boizeau P, Riviere S, Vizeneux A, Moretti R, Carbajal R, Mercier JC, Wood C, Zuccotti GV, Crichiutti G, Alberti C, Titomanlio L. Association between childhood migraine and history of infantile colic. JAMA. 2013 Apr 17;309(15):1607-12. doi: 10.1001/jama.2013.747.
    Results Reference
    background
    PubMed Identifier
    19604166
    Citation
    Savino F, Cordisco L, Tarasco V, Calabrese R, Palumeri E, Matteuzzi D. Molecular identification of coliform bacteria from colicky breastfed infants. Acta Paediatr. 2009 Oct;98(10):1582-8. doi: 10.1111/j.1651-2227.2009.01419.x. Epub 2009 Jul 9.
    Results Reference
    background
    PubMed Identifier
    23319531
    Citation
    de Weerth C, Fuentes S, Puylaert P, de Vos WM. Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics. 2013 Feb;131(2):e550-8. doi: 10.1542/peds.2012-1449. Epub 2013 Jan 14.
    Results Reference
    background
    PubMed Identifier
    15244234
    Citation
    Savino F, Cresi F, Pautasso S, Palumeri E, Tullio V, Roana J, Silvestro L, Oggero R. Intestinal microflora in breastfed colicky and non-colicky infants. Acta Paediatr. 2004 Jun;93(6):825-9.
    Results Reference
    background
    PubMed Identifier
    15893282
    Citation
    Iacono G, Merolla R, D'Amico D, Bonci E, Cavataio F, Di Prima L, Scalici C, Indinnimeo L, Averna MR, Carroccio A; Paediatric Study Group on Gastrointestinal Symptoms in Infancy. Gastrointestinal symptoms in infancy: a population-based prospective study. Dig Liver Dis. 2005 Jun;37(6):432-8. doi: 10.1016/j.dld.2005.01.009. Epub 2005 Mar 2.
    Results Reference
    background
    PubMed Identifier
    16678553
    Citation
    Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006 Apr;130(5):1377-90. doi: 10.1053/j.gastro.2006.03.008. No abstract available.
    Results Reference
    background
    PubMed Identifier
    16581954
    Citation
    Charrois TL, Sandhu G, Vohra S. Probiotics. Pediatr Rev. 2006 Apr;27(4):137-9. doi: 10.1542/pir.27-4-137. No abstract available.
    Results Reference
    background
    Citation
    http://www.biogaia.com/lactobacillus-reuter
    Results Reference
    background
    PubMed Identifier
    3245697
    Citation
    Talarico TL, Casas IA, Chung TC, Dobrogosz WJ. Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimicrob Agents Chemother. 1988 Dec;32(12):1854-8. doi: 10.1128/AAC.32.12.1854.
    Results Reference
    background
    PubMed Identifier
    22955349
    Citation
    Morelli L, Capurso L. FAO/WHO guidelines on probiotics: 10 years later. J Clin Gastroenterol. 2012 Oct;46 Suppl:S1-2. doi: 10.1097/MCG.0b013e318269fdd5. No abstract available.
    Results Reference
    background
    Citation
    Lifschitz C. Probiotics: Implications for Paediatric Health, Nestlé Nutrition Institute, South Asia Workshop Proceedings Vol. 1, Issue 1, 2013
    Results Reference
    background
    PubMed Identifier
    17200238
    Citation
    Savino F, Pelle E, Palumeri E, Oggero R, Miniero R. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics. 2007 Jan;119(1):e124-30. doi: 10.1542/peds.2006-1222.
    Results Reference
    background
    PubMed Identifier
    20713478
    Citation
    Savino F, Cordisco L, Tarasco V, Palumeri E, Calabrese R, Oggero R, Roos S, Matteuzzi D. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics. 2010 Sep;126(3):e526-33. doi: 10.1542/peds.2010-0433. Epub 2010 Aug 16.
    Results Reference
    background
    PubMed Identifier
    24424486
    Citation
    Chumpitazi BP, Shulman RJ. Five probiotic drops a day to keep infantile colic away? JAMA Pediatr. 2014 Mar;168(3):204-5. doi: 10.1001/jamapediatrics.2013.5002. No abstract available.
    Results Reference
    background
    PubMed Identifier
    24100440
    Citation
    Sung V, Collett S, de Gooyer T, Hiscock H, Tang M, Wake M. Probiotics to prevent or treat excessive infant crying: systematic review and meta-analysis. JAMA Pediatr. 2013 Dec;167(12):1150-7. doi: 10.1001/jamapediatrics.2013.2572.
    Results Reference
    background
    PubMed Identifier
    24424513
    Citation
    Indrio F, Di Mauro A, Riezzo G, Civardi E, Intini C, Corvaglia L, Ballardini E, Bisceglia M, Cinquetti M, Brazzoduro E, Del Vecchio A, Tafuri S, Francavilla R. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. JAMA Pediatr. 2014 Mar;168(3):228-33. doi: 10.1001/jamapediatrics.2013.4367.
    Results Reference
    background

    Learn more about this trial

    Prevention of Colic With the Probiotic Lactobacillus Reuteri

    We'll reach out to this number within 24 hrs